The European Commission adopted, on Friday (29 January), an export control mechanism on vaccines produced in EU countries - as a response to the shortfall of vaccines suddenly announced by the pharmaceutical company AstraZeneca earlier this month.
"The aim is to provide greater clarity on vaccine production in the EU and their exports - this transparency has been lacking and is vital at this time," said EU trade commissioner Valdis...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? LoginElena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.
Elena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.